ARTICLE SUMMARY:
The treatment of breast cancer today commonly entails repeat breast conserving surgeries due to imprecise methods of locating and measuring tumors during surgery. These lead to unnecessary expenditures of over $1 billion across the US and Europe. To help surgeons reduce these follow-up surgeries, OncoRes Medical is developing a probe that detects residual tumor within the surgical cavity in real time using OCT-E.
Breast cancer is the most common type of cancer in women across the world, impacting nearly a quarter of a million women in the US annually and killing roughly 20% of those diagnosed, according to the CDC.
